Insulet Wins Massive $452 Million in Trade Secret Lawsuit Against EOFlow Over Insulin Device Innovations
BOSTON — In a landmark legal decision, Insulet Corp., headquartered in Massachusetts, triumphed in a major trade secrets lawsuit against South Korea-based EOFlow Co. Ltd., with a federal jury awarding the U.S. medical device maker a colossal $452 million. The verdict, reached on Tuesday, marks a significant moment in the realm of intellectual property rights within the highly competitive medical device industry. Insulet Corp. has been developing its innovative OmniPod insulin pump since the early 2000s, a device that has significantly impacted the management of diabetes through its advanced, wearable technology. The lawsuit emerged following … Read more